Scholar Rock to Present at 2016 Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Scholar Rock, a biotechnology company focused on discovering and
developing drugs that selectively target supracellular activation of
growth factors in the disease microenvironment, today announced that
Nagesh Mahanthappa, PhD, President and Chief Executive Officer of
Scholar Rock, will present a company overview at the 2016 Wedbush
PacGrow Healthcare Conference on Wednesday, August 17, 2016, at 3:05
p.m. EDT in New York, NY.

About Scholar Rock

Scholar Rock is a biotechnology company focused on discovering and
developing a novel class of biologic therapies that target supracellular
activation of growth factors in the disease microenvironment. The
Company’s initial proprietary and partnered drug discovery programs
target specific growth factors which are present in the
microenvironments of significant diseases, including fibrosis,
musculoskeletal diseases, immuno-oncology and autoimmune diseases.
Scholar Rock was founded upon discoveries made by its scientific
founders, Professors Timothy Springer, PhD, and Leonard Zon, MD, of
Boston Children’s Hospital and Harvard Medical School, related to the
molecular mechanisms of supracellular activation. The company is backed
by leading investors, including Polaris Partners, Timothy Springer, ARCH
Venture Partners, Fidelity Investments, EcoR1 Capital, The Kraft Group,
and Cormorant Asset Management.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160811005233/en/